Healix
Healix is a US outpatient infusion management platform operating 220+ physician-owned and ambulatory infusion centers across 38 states, offering infusion management, pharmacy, wholesale distribution, manufacturer hub services, and clinical outcomes research in infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology.
- Company typePrivate
- Founded1989
- HeadquartersSugar Land, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Healix does
Healix is a US-based outpatient infusion management platform founded in 1989 and headquartered in Sugar Land, Texas, operating 220+ (with the company's About Us page citing 230+) physician-owned and ambulatory infusion centers across 38 states. The company specializes in therapeutic areas including infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology, delivering care in physician office and ambulatory settings as an alternative to hospital-based infusion.
The platform is built around six integrated service lines: infusion management services (drug procurement, revenue cycle management, nursing and pharmacy staffing); Healix Infusion Care, a company-managed ambulatory infusion center network; ACHC-accredited 503A pharmacy services with USP <797> and <800> compliant sterile compounding; NABP-accredited wholesale distribution from a 20,000 sq ft facility handling 60 NDCs; clinical outcomes research leveraging what Healix describes as the largest data warehouse in the outpatient infusion industry; and outsourced patient support and hub services (benefits verification, prior authorization, appeals, copay support) for pharmaceutical manufacturers. Underlying technology includes proprietary infusion management software, real-time financial and KPI reporting, and blockchain-enabled supply chain traceability.
Healix generates revenue through a mix of managed-services fees, drug margin on procured and infused medications, wholesale distribution fees, professional services for manufacturer hub programs, and collaborative research arrangements with pharmaceutical companies such as Ferring Pharmaceuticals and Melinta Therapeutics. The company sells primarily through direct enterprise partnerships with physician practices, hospital systems, and ambulatory infusion centers, supported by Client Services Executives and active participation at industry conferences across multiple specialties. In June 2026, Healix was acquired by Singlepoint Healthcare, a DFW Capital Partners-backed platform, becoming Singlepoint's third specialty infusion acquisition in roughly a year alongside The Boster Center for Multiple Sclerosis and IV Solutions.
Healix firmographics
Firmographics- Name
- Healix
- Legal name
- Healix
- Website
- https://healix.net
- Company type
- Private
- Founded year
- 1989
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- Healix is a US outpatient infusion management platform operating 220+ physician-owned and ambulatory infusion centers across 38 states, offering infusion management, pharmacy, wholesale distribution, manufacturer hub services, and clinical outcomes research in infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology.
- Ownership category
- akta.pro rank
Healix industry classification
Industry- Product category
- Outpatient Infusion Management Services
- NAICS
- Outpatient Care Centers (6214), Other Ambulatory Health Care Services (6219), Ambulatory Health Care Services (621)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Infusion Therapy Centers (Outpatient) (HLAFABAF)
- akta.pro secondary industries
- Infusion & Home Infusion Pharmacy Services (HLAFALAG), Home Infusion Therapy Providers (HLAFAEAE), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
Keywords
Where Healix is headquartered
LocationHeadquarters
- HQ city
- Sugar Land
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Healix business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Infusion Center Management Services: Comprehensive management services for physician-owned and ambulatory infusion centers including drug procurement, revenue cycle management, managed care programs, and clinical staffing. Revenue generated through operational fees and drug margin on infused medications.
- Pharmacy Services: Accredited pharmacy offering patient-specific injectable and infusion medications, sterile compounding, and clinical pharmacy services 24/7 to hospital systems, institutions, and outpatient facilities nationwide.
- Wholesale Distribution: Pharmaceutical distribution services spanning 60 National Drug Codes (NDCs) across 38 states through a 20,000 sq ft distribution center. Revenue from distribution fees and drug margin.
- Hub/Patient Support Services: Outsourced patient support services for pharmaceutical manufacturers including benefits verification, prior authorization, appeals facilitation, and copay support services.
- Clinical Outcomes Research: Collaborative research with manufacturers and physicians to study novel therapies, compare treatment sites, and conduct cutting-edge research using Healix's extensive data warehouse.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Healix product offering
Product offeringCore offering
Healix provides comprehensive outpatient infusion management services to physician practices, hospital systems, and pharmaceutical manufacturers, including drug procurement, revenue cycle management, managed care programs, clinical staffing, and on-site pharmacy support. The company operates a network of more than 220 physician-owned and ambulatory infusion centers across the United States, an ACHC-accredited 503A sterile compounding pharmacy in Sugar Land, Texas, and a wholesale pharmaceutical distribution network spanning 38 states with 60 National Drug Codes. Additional offerings include outsourced patient support/hub services for manufacturers and clinical outcomes research powered by what Healix describes as the largest data warehouse in the outpatient infusion industry.
Product overview
Healix is a comprehensive outpatient infusion management platform offering six interconnected service lines: Infusion Management Services (physician office-based management with drug procurement, revenue cycle, nursing, and pharmacy components), Ambulatory Infusion Centers (Healix-owned clinic network), Pharmacy Services (ACHC-accredited 503A sterile compounding pharmacy), Wholesale Distribution (pharmaceutical distribution with 60 NDCs across 38 states), Clinical Outcomes Research (data warehouse and real-world evidence studies), and Outsourced Patient Support and Hub Services (manufacturer patient access services). The company operates over 230 infusion centers nationwide, specializing in infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology. Sub-products include Drug Procurement Services, Revenue Cycle Services, Core Infusion Services, Nursing Infusion Services, and Pharmacy Infusion Services.
Differentiator
Problem solved
Functional benefit
Products and services
- Infusion Management Services Physician office-based infusion management services providing drug procurement, revenue cycle management, managed care programs, and clinical staffing to help healthcare providers deliver infusion therapies in outpatient settings.
- Ambulatory Infusion Centers (Healix Infusion Care)
Quantifiable outcome
- Significant cost savings demonstrated in outpatient treatment vs. hospital settings for conditions including MRSA infections, septicemia, and skin infections
- +3 more outcomes
Companies that use Healix
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Healix technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Healix partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- AlertMediaminorAlertMedia partners with Healix to provide a comprehensive global travel risk management solution. The partnership delivers end-to-end global travel risk management for organizations with international operations or travelers.
- Ferring PharmaceuticalscoreHealix collaborates with Ferring Pharmaceuticals on clinical research, including studies on fecal microbiota live-jslm for the prevention of recurrent Clostridioides difficile infection presented at ACG 2025.
- Melinta TherapeuticscoreHealix collaborates with Melinta Therapeutics on clinical studies including real-world experience with Rezafungin, a novel long-acting echinocandin, presented at ESCMID Global 2025.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Healix competitors and assessment
Company assessmentDirect peers
- Soleo Health: Specialty infusion services company offering home and alternate-site infusion therapies, specialty pharmacy, and clinical management - directly comparable to Healix's physician office management and ambulatory infusion center offerings.
- Vital Care Infusion Services: Franchise network of ambulatory infusion centers providing outpatient infusion services to physician practices, directly competing with Healix's physician office management and AIC service lines across multiple states.
- Amerita: Specialty infusion and home infusion pharmacy provider (KKR-backed) serving patients with chronic and complex conditions; competes with Healix across home/site-of-care infusion delivery.
- BioMatrix Specialty Pharmacy: Specialty pharmacy focused on infused and injectable therapies for chronic conditions including autoimmune disorders, offering home infusion and patient support services that overlap with Healix's pharmacy and hub services lines.
- Option Care Health: Largest independent provider of home and alternate-site infusion services in the US, with a national footprint and broad specialty infusion capabilities overlapping directly with Healix's physician office and ambulatory infusion center model.
- IV Solutions: Provider of outpatient infusion services now operating as a sister company to Healix within Singlepoint Healthcare, sharing the same specialty infusion and chronic disease focus.
Emerging players
- ContinuumRx: Specialty infusion services provider focused on hospital-system joint ventures for outpatient infusion, overlapping with Healix's institutional pharmacy and ambulatory infusion offerings.
Broad incumbents
- Coram (CVS Health): CVS Health's home infusion and specialty pharmacy arm; offers overlapping infusion services at much greater scale and with vertically integrated payer (Caremark) and retail capabilities.
- Walgreens Specialty Pharmacy: Large retail-backed specialty pharmacy providing infusion, injectable therapy management, and hub services that compete with Healix for manufacturer and physician partnerships.
Others
- McKesson: Largest US pharmaceutical wholesaler; competes with Healix's wholesale distribution arm and also operates US Oncology Network infusion services, providing both supply-side and downstream infusion exposure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Healix social profiles
Digital presenceHealix compliance and trust
Trust signalCompliance3 records
Healix financial estimates
Financial estimateRevenue estimate
Valuation estimate
Healix leadership team
Management profileNumber of profiles
Profiles10 records
Healix funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Healix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Healix
What does Healix do?
Healix provides comprehensive outpatient infusion management services to physician practices, hospital systems, and pharmaceutical manufacturers, including drug procurement, revenue cycle management, managed care programs, clinical staffing, and on-site pharmacy support. The company operates a network of more than 220 physician-owned and ambulatory infusion centers across the United States, an ACHC-accredited 503A sterile compounding pharmacy in Sugar Land, Texas, and a wholesale pharmaceutical distribution network spanning 38 states with 60 National Drug Codes. Additional offerings include outsourced patient support/hub services for manufacturers and clinical outcomes research powered by what Healix describes as the largest data warehouse in the outpatient infusion industry.
Is Healix a public or private company?
Healix is a private company. It is classified as private equity controlled and is currently acquired.
When was Healix founded?
Healix was founded in 1989. It employs 251 to 500 people.
Where is Healix based?
Healix is headquartered in Sugar Land, United States, in the North America region.
How does Healix make money?
Five revenue lines are on record. Infusion Center Management Services are the primary driver. The others are pharmacy Services, wholesale Distribution, hub/Patient Support Services and clinical Outcomes Research.
Who are Healix's main competitors?
Direct peers on record are Soleo Health, Vital Care Infusion Services, Amerita, BioMatrix Specialty Pharmacy, Option Care Health and IV Solutions. ContinuumRx is listed as an emerging player. Broad incumbents are Coram (CVS Health) and Walgreens Specialty Pharmacy. McKesson is listed as an others.
Does Healix have an API?
No public API is recorded for Healix.
What industry is Healix in?
Healix's product category is Outpatient Infusion Management Services. Its primary akta.pro industry code is HLAFABAF, Infusion Therapy Centers (Outpatient), with a secondary code of HLAFALAG, Infusion & Home Infusion Pharmacy Services. Its NAICS code is 6214 and its SIC code is 8093.